Medical experts are questioning whether digital breast tomosynthesis, also known as 3D mammography, will contribute to lowering the breast cancer death rate or normalize the overtreatment of cancers that may never have progressed, The New York Times reported Dec. 9.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
